[在晚期慢性肝病中预防脱补偿]
Deutsche medizinische Wochenschrift (1946)
|October 10, 2025
概括
在晚期慢性肝病 (ACLD) 中,临床显著的门性高血压 (CSPH) 的早期干预至关重要. 非选择性β抑制剂可以防止脱补偿,改善肝脏患者的治疗结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 晚期慢性肝病 (ACLD) 进展到去补偿带来高死亡率.
- 临床显著的门性高血压 (CSPH),定义为肝静脉压梯度 (HVPG) ≥10 mmHg,是脱补偿的主要驱动因素.
- 预防最初的减补事件,特别是,是关键的治疗目标.
研究的目的:
- 突出在ACLD中早期识别和管理CSPH的重要性.
- 审查非选择性β抑制剂 (NSBBs) 在预防脱补偿方面的作用.
- 强调及时干预对患者结果的影响.
主要方法:
- 文献综述侧重于CSPH,脱补偿和ACLD的治疗策略.
- 对评估用于风险识别的非侵入性工具 (如短暂弹性学) 的研究进行分析.
- 对NSBB的临床试验数据的检查,包括carvedilol,用于门口压力降低和降解补偿的预防.
主要成果:
- 在ACLD中,CSPH是不补偿的关键决定因素.
- 非侵入性弹性图形学有助于识别有风险的患者.
- 像卡维迪醇这样的NSBBs有效地降低了门口压力,并防止了不补偿,无论状况如何.
- 改变生活方式和治疗肝脏的根本原因是很重要的.
结论:
- 早期发现和治疗CSPH对于改变肝硬化自然史至关重要.
- 启动治疗,包括NSBBs,可以显著改善结果,并减少ACLD患者的死亡率.
- 结合药理疗法,生活方式改变和解决根本原因的多方面的方法对于最佳的患者护理至关重要.
相关概念视频
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
212
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
212
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
01:28Esophageal Varices-II: Clinical Features and Management
368
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
368
01:29Chronic Pancreatitis II: Collaborative Care
311
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
311
01:18Chronic Kidney Disease IV: Nursing Management
321
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
321
01:30Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218